CredFlow and OneCell Diagnostics Secure $19.7M to Drive Fintech and Precision Oncology Innovations

CredFlow and OneCell Diagnostics Secure $19.7M to Drive Fintech and Precision Oncology Innovations

CredFlow and OneCell Diagnostics Raise $19.7M to Innovate Finance and Healthcare

Two industry-leading startups, CredFlow and OneCell Diagnostics, have secured a combined funding of $19.7 million. These funds aim to drive advancements in SME financial management and precision cancer diagnostics.

CredFlow Simplifies Cash Flow Management for SMEs

CredFlow, a Delhi-based fintech company, has raised $3.7 million in a pre-Series B round. The funding was co-led by Inflexor Ventures and a Singapore-based family office.

What CredFlow Offers

CredFlow provides a cash flow management platform tailored for small and medium enterprises (SMEs). Its features include:

  • Real-time analytics on pending payments.
  • Automated payment reminders.
  • Invoice validation and early payment discount tools.

Impact and Reach

  • Over 1.5 lakh SMEs have benefited from CredFlow’s solutions.
  • The platform has processed $600 billion worth of invoices.
  • It captures nearly 50% of GST-related businesses in India.

Plans for the Future

The fresh funds will enhance CredFlow’s lending services and further develop its technology.

OneCell Diagnostics Leads in Cancer Detection Innovation

OneCell Diagnostics, a cancer diagnostics startup operating in India and Silicon Valley, raised $16 million in Series A funding. The round was led by Celesta Capital, with participation from Tenacity Ventures, Cedars Sinai, Eragon, and Singularity Ventures.

Advanced Cancer Diagnostic Solutions

OneCell specializes in liquid biopsy technology. Its flagship product, OncoIndx Ikon, detects circulating tumor cells to provide:

  • Early cancer detection.
  • Monitoring of treatment effectiveness.
  • Tracking of disease progression and recurrence.

Innovative Technology

OneCell combines next-generation sequencing with AI-driven bioinformatics to improve precision in oncology care.

Strategic Partnerships

The startup collaborates with renowned institutions such as:

  • AIIMS
  • Tata Memorial Centre
  • Harvard Medical School
  • Stanford University

Future Goals

The company will use the funding to expand into the US market and make its diagnostic solutions more accessible and affordable globally.